315 related articles for article (PubMed ID: 8836116)
1. The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation.
Naseem KM; Chirico S; Mohammadi B; Bruckdorfer KR
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):759-66. PubMed ID: 8836116
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
3. Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
Sabetkar M; Naseem KM; Tullett JM; Friebe A; Koesling D; Bruckdorfer KR
Nitric Oxide; 2001 Jun; 5(3):233-42. PubMed ID: 11384196
[TBL] [Abstract][Full Text] [Related]
4. Copper chelation-induced reduction of the biological activity of S-nitrosothiols.
Gordge MP; Meyer DJ; Hothersall J; Neild GH; Payne NN; Noronha-Dutra A
Br J Pharmacol; 1995 Mar; 114(5):1083-9. PubMed ID: 7780643
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
Megson IL; Sogo N; Mazzei FA; Butler AR; Walton JC; Webb DJ
Br J Pharmacol; 2000 Dec; 131(7):1391-8. PubMed ID: 11090112
[TBL] [Abstract][Full Text] [Related]
6. Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Neild GH; Dutra AA
Br J Pharmacol; 1996 Oct; 119(3):533-8. PubMed ID: 8894174
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
Mellion BT; Ignarro LJ; Myers CB; Ohlstein EH; Ballot BA; Hyman AL; Kadowitz PJ
Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
[TBL] [Abstract][Full Text] [Related]
8. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.
Freedman JE; Frei B; Welch GN; Loscalzo J
J Clin Invest; 1995 Jul; 96(1):394-400. PubMed ID: 7615810
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
Sogo N; Magid KS; Shaw CA; Webb DJ; Megson IL
Biochem Biophys Res Commun; 2000 Dec; 279(2):412-9. PubMed ID: 11118301
[TBL] [Abstract][Full Text] [Related]
10. S-nitroso-glutathione inhibits platelet activation in vitro and in vivo.
Radomski MW; Rees DD; Dutra A; Moncada S
Br J Pharmacol; 1992 Nov; 107(3):745-9. PubMed ID: 1335336
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet aggregation by S-nitroso-cysteine via cGMP-independent mechanisms: evidence of inhibition of thromboxane A2 synthesis in human blood platelets.
Tsikas D; Ikic M; Tewes KS; Raida M; Frölich JC
FEBS Lett; 1999 Jan; 442(2-3):162-6. PubMed ID: 9928994
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosoglutathione/glutathione disulphide/Cu2+-dependent stimulation of L-arginine transport in human platelets.
Howard CM; Sexton DJ; Mutus B
Thromb Res; 1998 Aug; 91(3):113-20. PubMed ID: 9733154
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.
Irwin C; Roberts W; Naseem KM
Platelets; 2009 Nov; 20(7):478-86. PubMed ID: 19852686
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets.
Naseem KM; Bruckdorfer KR
Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):149-53. PubMed ID: 7646437
[TBL] [Abstract][Full Text] [Related]
16. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
Sogo N; Campanella C; Webb DJ; Megson IL
Br J Pharmacol; 2000 Nov; 131(6):1236-44. PubMed ID: 11082133
[TBL] [Abstract][Full Text] [Related]
17. YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase.
Wu CC; Kuo SC; Lee FY; Teng CM
Eur J Pharmacol; 1999 Sep; 381(2-3):185-91. PubMed ID: 10554886
[TBL] [Abstract][Full Text] [Related]
18. Characterization of bronchodilator effects and fate of S-nitrosothiols in the isolated perfused and ventilated guinea pig lung.
Bannenberg G; Xue J; Engman L; Cotgreave I; Moldéus P; Ryrfeldt A
J Pharmacol Exp Ther; 1995 Mar; 272(3):1238-45. PubMed ID: 7891339
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor.
Simon DI; Stamler JS; Jaraki O; Keaney JF; Osborne JA; Francis SA; Singel DJ; Loscalzo J
Arterioscler Thromb; 1993 Jun; 13(6):791-9. PubMed ID: 8388713
[TBL] [Abstract][Full Text] [Related]
20. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
Chirkov YY; Belushkina NN; Tyshchuk IA; Severina IS; Horowitz JD
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):517-24. PubMed ID: 1680588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
